Showing results (111-120 of 122) with videos related to
Sort By:
Pageof 13
JACC. Cardiooncology|March 5, 2025
Cardiac Effects of Modern Breast Radiation Therapy in Patients Receiving Systemic Cancer TherapyEva Berlin, Kyunga Ko, Lin Ma, et al.Cancer Discovery|April 3, 2023
Type I Interferon Signaling via the EGR2 Transcriptional Regulator Potentiates CAR T Cell-Intrinsic DysfunctionIn-Young Jung, Robert L Bartoszek, Andrew J Rech, et al.Breast Cancer Research and Treatment|April 2, 2025
Risk-guided cardioprotection with carvedilol in patients with breast cancer (CCT guide): a phase 1 randomized clinical trialWonyoung Jung, Rebecca A Hubbard, Amanda M Smith, et al.JAMA Oncology|November 17, 2022
Avelumab Plus Talazoparib in Patients With BRCA1/2- or ATM-Altered Advanced Solid Tumors: Results From JAVELIN BRCA/ATM, an Open-Label, Multicenter, Phase 2b, Tumor-Agnostic TrialAlison M Schram, Nicoletta Colombo, Edward Arrowsmith, et al.Medrxiv : the Preprint Server for Health Sciences|August 20, 2025
Pathogenic germline variants in a racially diverse real-world cohort of prostate cancer patientsTaylor B Crawford, Maliha Tayeb, Emanuel Barrett, et al.Journal of the National Comprehensive Cancer Network : JNCCN|June 2, 2026
Pathogenic Germline Variants in a Racially Diverse Real-World Cohort of Patients With Prostate CancerTaylor B Crawford, Maliha Tayeb, Emanuel Barrett, et al.Eclinicalmedicine|June 12, 2023
Metastatic renal cell carcinoma to the pancreas and other sites-a multicenter retrospective studyCassandra Duarte, Junxiao Hu, Benoit Beuselinck, et al.Prostate Cancer and Prostatic Diseases|February 28, 2024
Natural Killer Cell Infiltration in Prostate Cancers Predict Improved Patient OutcomesNicholas A Zorko, Allison Makovec, Andrew Elliott, et al.JAMA Network Open|December 3, 2025
Biomarker-Guided Cardioprotection for Patients Treated With Anthracyclines: A Randomized Clinical TrialCongying Xia, Amanda M Smith, Bénédicte Lefebvre, et al.Cancer|August 3, 2021
Genetic risk assessment for hereditary renal cell carcinoma: Clinical consensus statementGennady Bratslavsky, Neil Mendhiratta, Michael Daneshvar, et al.Pageof 13